2m 2m 2m 2m 2m 2m 2m
SUMMIT THERAP (SMMT)
NASDAQ
$15.23-$0.08 (-0.49%)
Price as of Jul 13, 2026 7:46 PM EDT- $11.8BMarket Cap
- -39.76%1-Year Change
- BiotechnologyIndustry
SUMMIT THERAP (SMMT)
$15.23-$0.08 (-0.49%)
SMMT | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $15.30 | ||
Change | +$0.05 (+0.33%) | ||
Open | $15.11 | ||
High | $15.47 | ||
Low | $14.79 | ||
Previous Close | $15.25 | ||
Volume | 3,389,953 | ||
30-Day Average Volume | 5,165,070 | ||
1-Week Change | -3.95% | ||
1-Month Change | 9.21% | ||
1-Year Change | -39.76% | ||
3-Year Change | 595.45% | ||
5-Year Change | 109.88% | ||
Fundamentals | |||
Shares Outstanding | 776.2M | ||
Total Assets | $647.9M | ||
Market Cap | $11.8B | ||
Enterprise Value | $11.7B | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$189.4M | ||
Free Cash Flow | -$122.5M | ||
EBIT | -$189.4M | ||
EBITDA | -$189.4M | ||
Net Working Capital | $533.3M | ||
EPS | -$0.24 | ||
Enterprise Value/EBITDA | -62 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 22 | ||
P/E | -64 | ||
PEG | -4 | ||
Price/Free Cash Flow | -97 | ||
Price/Operating Cash Flow | -97 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue